Antithrombin-independent effects of heparins on fibrin clot nanostructure

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 5, 2012, Pages 1320-1324

  Yeromonahos, Christelle ^a   Marlu, Raphaël ^b,c   Polack, Benoît ^b,c   Caton, Francois ^a  

^a Univ Joseph Fourier Grenoble 1   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c LABORATOIRE TIMC IMAG   (France)

Author keywords

Fibrin fibers; Fondaparinux; Low molecular weight heparin; Nanostructure; Spectrophotometry; Unfractionated heparin

Indexed keywords

FIBRIN; FIBRINOGEN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN;

ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; FIBRIN CLOT; HUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; SPECTROMETRY;

BLOOD COAGULATION; FIBRIN; FIBRINOGEN; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; SPECTROPHOTOMETRY; THROMBIN; THROMBOSIS;

EID: 84860123901     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.245308     Document Type: Article

References (35)

1. Weisel JW. The mechanical properties of fibrin for basic scientists and clinicians. Biophys Chem. 2004;112:267-276. (Pubitemid 39574429)
2. Collet JP, Soria J, Mirshahi M, Hirsch M, Dagonnet FB, Caen J, Soria C. Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure. Blood. 1993;82:2462-2469. (Pubitemid 23304270)
3. Mosseson MW. Dysfibrinogenemia and thrombosis. Semin Thromb Hemost. 1999;25:311-319.
4. Piechocka IK, Bacabac RG, Potters M, Mackintosh FC, Koenderink GH. Structural hierarchy governs fibrin gel mechanics. Biophys J. 2010;98:2281-2289.
5. Carr ME, Hermans J. Size and density of fibrin fibers from turbidity. Macromolecules. 1978;11:46-50.
6. Bernocco S, Ferri F, Profumo A, Cuniberti C, Rocco M. Polymerization of rod-like macromolecular monomers studied by stopped-flow, multiangle light scattering: set-up, data processing, and application to fibrin formation. Biophys J. 2010;79:561-583.
7. Ferri F, Greco M, Arcovito G, Bassi FA, DeSpirito M. Growth kinetics and structure of fibrin gels. Phys Rev E. 2001;63:031401.
8. Ferri F, Greco M, Arcovito G, DeSpirito M, Rocco M. Structure of fibrin gels studied by elastic light scattering techniques: dependence of fractal dimension, gel crossover length, fiber diameter and fiber density on monomer concentration. Phys Rev E. 2002;66:011913.
9. Ryan EA, Mockros LF, Weisel JW, Lorand L. Structural origins of fibrin clot rheology. Biophys J. 1999;77:2813-2826. (Pubitemid 29519524)
10. DeSpirito M, Arcovito G, Papi M, Rocco M, Ferri F. Small and wide angle elastic light scattering study of fibrin structure. J Appl Cryst. 2003;36:636-641.
11. Hantgan RR, Hermans J. Assembly of fibrin: a light scattering study.J Biol Chem. 1979;254:11272-11281. (Pubitemid 10136141)
12. Weisel JW. Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides. Biophys J. 1986;50:85-13.
13. Hunziker EB, Straub PW, Haeberlis A. A new concept of fibrin formation based upon the linear growth of interlacing and branching polymers and molecular alignment into interlocked single-stranded segments. J Biol Chem. 1990;265:7455-7463.
14. Yeromonahos C, Polack B, Caton F. Nanostructure of the fibrin clot. Biophys J. 2010;99:2018-2027.
15. Choay J. Structure and activity of heparin and its fragments : an overview. Semin Thromb Hemost. 1989;15:359-364. (Pubitemid 19265834)
16. Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the seven ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:188S-203S. (Pubitemid 39297954)
17. Ferry JD, Morrison PR. Preparation and properties of serum and plasma proteins: the conversion of human fibrinogen to fibrin under various conditions. J Am Chem Soc. 1947;69:388-399.
18. Shulman S, Ferry JD, Tinoco I. The conversion of fibrinogen to fibrin XII: influence of pH, ionic strength and hexamethylene glycol concentration on the polymerization of fibrinogen. Arch Biochem Biophys. 1953;42:245-256.
19. Jung H, Tae G, Kim YH, Johannsmann D. Change of viscoelastic property and morphology of fibrin affected by antithrombin III and heparin: QCM-Z and AFM study. Colloids Surf B Biointerfaces. 2009;68:111-119.
20. Collen A, Smorenburg SM, Peters E, Lupu F, Koolwijk P, Van Noorden C, van Hinsbergh VW. Unfractioned and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res. 2000;60:6196-6200.
21. LeBoeuf RD, Gregg RR, Weigel PH, Fuller GM. Effects of hyaluronic acid and other glycosaminoglycans on fibrin polymer formation. Biochemistry. 1987;26:6052-6057. (Pubitemid 17153319)
22. Parise P, Morini M, Agnelli G, Ascani A, Nenci GG. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis. Blood Coagul Fibrinolysis. 1993;4:721-727. (Pubitemid 23343395)
23. Sato H, Nakajima A, Shimohira T. Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin (IV): effects of heparin and its analogues. Thromb Res. 1985;39:549-557. (Pubitemid 15228555)
24. Carr ME, Powers PL. Effect of glycosaminoglycans on thrombin-and Atroxin-induced fibrin assembly and structure. Thromb Haemost. 1989;62:1057-1061. (Pubitemid 20011489)
25. Varin R, Mirshahi S, Mirshahi P, Kierzek G, Sebaoun D, Mishal Z, Vannier JP, Borg JY, Simoneau G, Soria C, Soria J. Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activity. Thromb Haemost. 2007;97:27-31.
26. Hogg PJ, Jackson CM. Heparin promotes the binding of thrombin to fibrin polymer: quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex. J Biol Chem. 1990;265:241-247. (Pubitemid 20032335)
27. Hogg PJ, Jackson CM. Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates. J Biol Chem. 1990;265:248-255. (Pubitemid 20032336)
28. Hogg PJ, Jackson CM, Labanowski JK, Bock PE. Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen. J Biol Chem. 1996;271:26088-26095. (Pubitemid 26347450)
29. Paolucci F, Claviés MC, Donat F, Necciari J. Fondaparinux sodium mechanism of action: identification of specific binding to purified and human plasma-derived proteins. Clin Pharmacokinet. 2002;41:11-18. (Pubitemid 35155552)
30. Abildgaard U. Inhibition of the thrombin-fibrinogen reaction by heparin in absence of cofactor. Scand J Haematol. 1968;5:432-439.
31. Shinowara GY. Enzyme studies on human blood: interrelation of fibrin and fibrinogen fractions. Am J Physiol. 1949;156:458-466.
32. Godal HC. The influence of heparin on the fibrin clot. Scand J Clin Lab Invest. 1961;13:306-313.
33. Gralnick HR, Givelber HM, Finlayson JS. A new congenital abnormality of human fibrinogen: fibrinogen Bethesda II. Thromb Diath Haemorrh. 1973;29:563-571.
34. Hemker HK, Beguin S, Thrombin generation in plasma: its assessment via endogenous thrombin potential. Thromb Haemost. 1995;74:134-138.
35. Beguin S, Mardiguian J, Lindhout T, Hemker HC. The mode of action of low molecular heparin preparation (PK10169) and two of its major components on thrombin generation in plasma. Thromb Haemost. 1989;61:30-34. (Pubitemid 19092664)